Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-07
2006-02-07
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S256000, C514S311000, C514S332000, C514S333000, C544S333000, C546S162000, C546S255000, C546S256000
Reexamination Certificate
active
06995175
ABSTRACT:
The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
REFERENCES:
patent: 5767278 (1998-06-01), Gaeta et al.
patent: 5863936 (1999-01-01), Gaeta et al.
patent: 6362210 (2002-03-01), Hauel et al.
patent: 19935219 (2001-02-01), None
patent: 1147295 (1969-04-01), None
patent: WO 01/07020 (2001-02-01), None
patent: WO 01/40218 (2001-06-01), None
patent: WO 02/076975 (2002-10-01), None
Hiratani et al, Bulletin of the Chemical Society of Japan, vol. 63, No. 11, pp. 3331-3333, 1990.
Denny et al, Journal of Medicinal Chemistry, vol. 22, No. 2, pp. 134-150, 1979.
Bouchard Herve
Hittinger Augustin
Aventis Pharma S.A.
Davis Zinna Northington
Gupta Balaram
LandOfFree
Chemical derivatives and their application as antitelomerase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical derivatives and their application as antitelomerase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical derivatives and their application as antitelomerase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3669565